Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

CL Trotter; ME Ramsay

doi:10.1111/j.1574-6976.2006.00053.x

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

CL Trotter, ME Ramsay

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

140 Citations (Scopus)

Abstract

At the end of 2005, six European countries had implemented public immunisation campaigns with serogroup C conjugate vaccines to date and all had experienced substantial declines in the incidence of serogroup C disease. A quadrivalent ACWY meningococcal vaccine is in use in the USA, but serogroup A is extremely rare in Europe and serogroups Y and W-135 are infrequent causes of disease. This paper outlines recommendations about the use of conjugate vaccines in Europe, based on the experience with MCC vaccines so far.

Translated title of the contribution	Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines
Original language	English
Pages (from-to)	101 - 107
Number of pages	7
Journal	FEMS Microbiology Reviews
Volume	31 (1)
DOIs	https://doi.org/10.1111/j.1574-6976.2006.00053.x
Publication status	Published - Jan 2007

Bibliographical note

Publisher: Blackwell

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1574-6976.2006.00053.x

http://www.blackwell-synergy.com/doi/abs/10.1111/j.1574-6976.2006.00053.x

Handle.net

Persistent link

Cite this

@article{b04541fb1a764835b1fac67cff178dbd,

title = "Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines",

abstract = "At the end of 2005, six European countries had implemented public immunisation campaigns with serogroup C conjugate vaccines to date and all had experienced substantial declines in the incidence of serogroup C disease. A quadrivalent ACWY meningococcal vaccine is in use in the USA, but serogroup A is extremely rare in Europe and serogroups Y and W-135 are infrequent causes of disease. This paper outlines recommendations about the use of conjugate vaccines in Europe, based on the experience with MCC vaccines so far.",

author = "CL Trotter and ME Ramsay",

note = "Publisher: Blackwell",

year = "2007",

month = jan,

doi = "10.1111/j.1574-6976.2006.00053.x",

language = "English",

volume = "31 (1)",

pages = "101 -- 107",

journal = "FEMS Microbiology Reviews",

issn = "1574-6976",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

AU - Trotter, CL

AU - Ramsay, ME

N1 - Publisher: Blackwell

PY - 2007/1

Y1 - 2007/1

N2 - At the end of 2005, six European countries had implemented public immunisation campaigns with serogroup C conjugate vaccines to date and all had experienced substantial declines in the incidence of serogroup C disease. A quadrivalent ACWY meningococcal vaccine is in use in the USA, but serogroup A is extremely rare in Europe and serogroups Y and W-135 are infrequent causes of disease. This paper outlines recommendations about the use of conjugate vaccines in Europe, based on the experience with MCC vaccines so far.

AB - At the end of 2005, six European countries had implemented public immunisation campaigns with serogroup C conjugate vaccines to date and all had experienced substantial declines in the incidence of serogroup C disease. A quadrivalent ACWY meningococcal vaccine is in use in the USA, but serogroup A is extremely rare in Europe and serogroups Y and W-135 are infrequent causes of disease. This paper outlines recommendations about the use of conjugate vaccines in Europe, based on the experience with MCC vaccines so far.

U2 - 10.1111/j.1574-6976.2006.00053.x

DO - 10.1111/j.1574-6976.2006.00053.x

M3 - Article (Academic Journal)

C2 - 17168998

SN - 1574-6976

VL - 31 (1)

SP - 101

EP - 107

JO - FEMS Microbiology Reviews

JF - FEMS Microbiology Reviews

ER -

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines

Abstract

Bibliographical note

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this